Langrish CL, Bradshaw JM, Francesco MR, Owens TD, et al. Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease. J Immunol 2021;206:1454-1468.
PMID: 33674445